AI Chat
Loading data for RGEN — first visit, this takes a few seconds.

Repligen Corporation

RGEN · NasdaqGS · USD

178.19 +5.28 (3.05%)

At close: Sep 18, 2026, 5:56 PM

Market Cap
$10.04B
Volume
1.09M
Next earnings date
Nov 3, 2026

Repligen Corporation (RGEN) Stock Price, Analysis & Data

Intrinsic Value

Loading intrinsic value…

Analyst Forecast

Stock Forecasts →

Analyst forecast unavailable

12-month target · n/a analysts

Analyst Consensus: n/a

Interval:1D
Loading candles and signals…

Financial Performance

View financials →

Loading...

Latest Earnings

ReportedVs estimateYoY Change
Revenue$204.1Mn/a+11.93%
EPS$0.54+$0.09+45.95%

Next Earnings

before market opens.

Estimate · Upgrade →

View earnings details →

Metrics

Bid
177.95
Net Income (ttm)
41.5M
1.05
0.73
243.62
67.11
P/B (ttm)
4.75
P/S (ttm)
12.78
Earnings Date
Nov 3, 2026
Ask
189.54
Volume
1,086,011
Avg. Volume (20D)
1,110,882
Open
174.93
Previous Close
172.91
Day's Range
173.24 - 178.65
52-Week Range
100.99 - 188.73
Ex-Dividend Date
n/a

About Repligen Corporation

View profile →
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts. Medical Instruments & Supplies · Healthcare

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Sector Healthcare
IPO Date Apr 29, 1986
Employees 2,000
Stock Exchange NasdaqGS
Ticker Symbol RGEN